PL2775852T3 - Kompozycja do stosowania do wzrostu mózgu i/lub rozwoju funkcji poznawczych i/lub psychomotorycznych - Google Patents

Kompozycja do stosowania do wzrostu mózgu i/lub rozwoju funkcji poznawczych i/lub psychomotorycznych

Info

Publication number
PL2775852T3
PL2775852T3 PL12772784T PL12772784T PL2775852T3 PL 2775852 T3 PL2775852 T3 PL 2775852T3 PL 12772784 T PL12772784 T PL 12772784T PL 12772784 T PL12772784 T PL 12772784T PL 2775852 T3 PL2775852 T3 PL 2775852T3
Authority
PL
Poland
Prior art keywords
cognitive
composition
brain growth
psychomotor development
psychomotor
Prior art date
Application number
PL12772784T
Other languages
English (en)
Polish (pl)
Inventor
Clara Garcia-Rodenas
Kurt Ornstein
Original Assignee
Nestec S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47019022&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2775852(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec S.A. filed Critical Nestec S.A.
Publication of PL2775852T3 publication Critical patent/PL2775852T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11Medicinal preparations comprising living procariotic cells
    • A61K2035/115Probiotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Pediatric Medicine (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Obesity (AREA)
  • Botany (AREA)
  • Psychology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL12772784T 2011-10-18 2012-10-12 Kompozycja do stosowania do wzrostu mózgu i/lub rozwoju funkcji poznawczych i/lub psychomotorycznych PL2775852T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11185600 2011-10-18

Publications (1)

Publication Number Publication Date
PL2775852T3 true PL2775852T3 (pl) 2017-02-28

Family

ID=47019022

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12772784T PL2775852T3 (pl) 2011-10-18 2012-10-12 Kompozycja do stosowania do wzrostu mózgu i/lub rozwoju funkcji poznawczych i/lub psychomotorycznych

Country Status (16)

Country Link
US (1) US20140271562A1 (https=)
EP (2) EP3095331A1 (https=)
CN (1) CN103889238B (https=)
AU (1) AU2012325060B2 (https=)
BR (1) BR112014008944B1 (https=)
CL (1) CL2014000759A1 (https=)
ES (1) ES2601891T3 (https=)
IN (1) IN2014DN01468A (https=)
MX (1) MX350435B (https=)
MY (1) MY170185A (https=)
PH (1) PH12014500443A1 (https=)
PL (1) PL2775852T3 (https=)
PT (1) PT2775852T (https=)
RU (1) RU2607458C2 (https=)
WO (1) WO2013057049A1 (https=)
ZA (1) ZA201403591B (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2651067T3 (es) 2009-07-06 2018-01-24 Children's Hospital Medical Center Inhibición de la inflamación con oligosacáridos de la leche
DK2708147T3 (da) 2012-09-14 2020-05-18 Abbott Lab Fremgangsmåder til forøgelse af hjernefunktionalitet under anvendelse af 2-fucosyl-lactose
ES2572831T3 (es) 2012-09-14 2016-06-02 Abbott Laboratories Composiciones nutricionales para su uso en métodos para modular los niveles de corticosterona en individuos con estrés psicológico
EP2880993A1 (en) * 2013-12-04 2015-06-10 Abbott Laboratories Method of achieving memory and learning improvement by the administration of sialic acid
WO2015091789A2 (en) * 2013-12-19 2015-06-25 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
US20150305385A1 (en) * 2014-04-25 2015-10-29 Mead Johnson Nutrition Company Pediatric nutritional composition with human milk oligosaccahrides, prebiotics and probiotics
FR3020949B1 (fr) * 2014-05-16 2018-02-09 Ecole Normale Superieure De Lyon Composition permettant de favoriser la croissance juvenile humaine et animale en cas de malnutrition
AU2015340652B9 (en) * 2014-10-31 2020-04-16 Société des Produits Nestlé S.A. Composition comprising Fut2-dependent oligosaccharides and lacto-n-neotetraose for use in promoting brain development and cognition
MX2017006701A (es) * 2014-11-26 2018-02-13 Abbott Lab Fórmula infantil con rrr-alfa-tocoferol,2'-fucosilactosa y un probiótico.
WO2016145628A1 (en) * 2015-03-18 2016-09-22 Nestec S.A. Composition comprising siallyllactose for use in enhancing learning skills and memory function
EP3288389A4 (en) * 2015-04-28 2018-10-10 Children's Hospital Medical Center Use of oligosaccharide compositions to enhance weight gain
ES2772685T3 (es) * 2015-08-04 2020-07-08 Nestle Sa Composiciones nutricionales con 2FL y LNNT para inducir una microbiota intestinal similar a la de los bebés lactantes
EP3389668A4 (en) 2015-12-15 2019-08-21 Glycom A/S MIXTURE OF HMOS
AU2017213083A1 (en) * 2016-01-26 2018-05-10 Société des Produits Nestlé S.A. Compositions comprising sialylated oligosaccharides for use in infants or young children to prevent later in life obesity or related comorbidities and promote a healthy growth
MY186314A (en) * 2016-01-26 2021-07-08 Nestle Sa Compositions comprising 2fl and lnnt to control food intake and growth in infants or young children
EP3443969B1 (en) * 2016-04-13 2021-12-22 Meiji Co., Ltd. Use of bifidobacteria for improving developmental quotient in neonates
SG10202100843TA (en) 2016-07-28 2021-03-30 Fonterra Cooperative Group Ltd Dairy product and process
WO2018204670A1 (en) 2017-05-04 2018-11-08 The Board Of Trustees Of The Leland Stanford Junior University Neurodevelopment-promoting food compositions and kits, systems and methods related thereto
MX2019013683A (es) 2017-05-16 2020-01-15 Ability Pharmaceuticals Sl Una combinacion farmaceutica para el tratamiento de un cancer.
WO2018215406A1 (en) * 2017-05-24 2018-11-29 Nestec S.A. A nutritional composition for use to enhance attention and/or reduce impulsivity
EP3648617A1 (en) * 2017-07-07 2020-05-13 Société des Produits Nestlé S.A. Human milk fortifier
CN111093395A (zh) * 2017-07-07 2020-05-01 雀巢产品有限公司 人乳强化剂
RU2698564C1 (ru) * 2019-01-09 2019-08-28 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт охраны материнства и младенчества" Министерства здравоохранения Российской Федерации (ФГБУ "НИИ ОММ" Минздрава России) Способ прогнозирования риска развития гипотрофии у детей, родившихся в сроке сверхранних преждевременных родов, к скорригированному возрасту 6 месяцев
EP4255198A1 (en) 2020-12-04 2023-10-11 Société des Produits Nestlé S.A. Stable aqueous composition for preterm to promote early postnal growth
KR102570073B1 (ko) * 2022-11-17 2023-08-24 (주)에이피테크놀로지 2'-푸코실락토오스를 포함하는 치매 개선 또는 치료용조성물
CN118285505A (zh) * 2024-03-29 2024-07-05 黑龙江飞鹤乳业有限公司 促进大脑发育的营养组合物、食品及配方奶粉
WO2025257135A1 (en) 2024-06-10 2025-12-18 N.V. Nutricia Non-digestible oligosaccharide mixture for infants at risk of brain injury

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991016449A1 (en) 1990-04-16 1991-10-31 The Trustees Of The University Of Pennsylvania Saccharide compositions, methods and apparatus for their synthesis
US5545553A (en) 1994-09-26 1996-08-13 The Rockefeller University Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them
US20040048926A1 (en) * 2002-03-15 2004-03-11 Hoffman Dennis Robert Use of docosahexaenoic acid and arachidonic acid to enhance the visual development of term infants breast-fed up to the age of six months
ATE433674T1 (de) * 2003-06-23 2009-07-15 Nestec Sa Säuglingsnährpräparat oder folgemilch
CN1863463B (zh) * 2003-06-23 2011-05-04 雀巢技术公司 用于促进肠道屏障成熟的营养组合物
KR100857500B1 (ko) * 2003-06-30 2008-09-08 클라사도 인크. 신규한 갈락토올리고사카라이드 조성물 및 그 제조방법
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
CA2641842A1 (en) * 2006-02-10 2007-08-16 Nestec S.A. Oligosaccharide mixture
RU2448720C2 (ru) 2006-03-07 2012-04-27 Нестек С.А. Синбиотическая смесь
US20080003330A1 (en) 2006-06-30 2008-01-03 Ricardo Rueda Infant formulas for early brain development
BRPI0819445A2 (pt) * 2007-11-26 2015-12-22 Nestec Sa sistema de nutrição para recém-nascidos adaptado à idade
CN102459294A (zh) 2009-04-07 2012-05-16 格礼卡姆股份公司 2’-o-岩藻糖基乳糖的合成
EP2251030A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2258218A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
AU2010277582A1 (en) * 2009-07-31 2012-02-02 Nestec S.A. Nutritional composition for breast-fed infants or pets with probiotics and selected nutrients
EP3241836B1 (en) * 2010-02-19 2024-10-30 Glycom A/S Polymorph of a tetrasaccharide containing nacetyl-lactosamine
EP2404507A1 (en) 2010-07-08 2012-01-11 Nestec S.A. Array of age-tailored nutritional formula with optimum fat content
CA2836241A1 (en) * 2011-06-08 2012-12-13 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components

Also Published As

Publication number Publication date
BR112014008944B1 (pt) 2020-09-15
EP2775852B1 (en) 2016-08-17
ZA201403591B (en) 2016-01-27
MX350435B (es) 2017-09-06
MY170185A (en) 2019-07-09
BR112014008944A2 (pt) 2017-05-02
ES2601891T3 (es) 2017-02-16
PT2775852T (pt) 2016-11-08
WO2013057049A1 (en) 2013-04-25
PH12014500443A1 (en) 2014-04-14
EP3095331A1 (en) 2016-11-23
MX2014004716A (es) 2015-02-05
CL2014000759A1 (es) 2014-08-22
RU2014119844A (ru) 2015-11-27
US20140271562A1 (en) 2014-09-18
AU2012325060B2 (en) 2015-11-19
IN2014DN01468A (https=) 2015-05-22
EP2775852A1 (en) 2014-09-17
RU2607458C2 (ru) 2017-01-10
CN103889238A (zh) 2014-06-25
CN103889238B (zh) 2017-10-13
AU2012325060A1 (en) 2014-03-13

Similar Documents

Publication Publication Date Title
PT2775852T (pt) Composição para utilização no crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
EP2749259A4 (en) FAT LOSS AND WEIGHT LOSS METHOD AND WEIGHT LOSS INSTRUMENT THEREWITH
GB2511995B (en) Apparatus for stimulating hair growth and/or preventing hair loss
ZA201309669B (en) Immunoconjugates,composition containing them,and methods of making and use
GB201400072D0 (en) Implant and implant system
ZA201400562B (en) Axmi205 variant proteins and methods for their use
PT2663864T (pt) Método de avaliação de imunodiversidade e seu uso
GB201122195D0 (en) Composition and method
GB201111705D0 (en) Compounds and their use
GB201408236D0 (en) Composition and method
IL238274A0 (en) Methods and preparations for local increase of body fat
SG11201402380RA (en) Polymeric blends and methods of using same
GB201117106D0 (en) Prosthesis and methods and uses involving said prosthesis
GB201218084D0 (en) Novel compounds and methods for use in medicine
PL2667710T3 (pl) Kompozycja owadobójcza i związane z nią sposoby
GB201106433D0 (en) Composition and method
IL232174A0 (en) Preparations containing a salt of a sodium channel inhibitor and their uses
GB201114448D0 (en) Compounds and their use
ZA201408419B (en) Methods and composition for enhanced forage quality
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
GB2509033B (en) Composition for coloring skin and method for coloring skin
PL2674148T3 (pl) Środek na porost włosów / tonik do włosów
SG11201402395YA (en) Continuous body ofwristbands and wristband
SG10201500715XA (en) Composition for Multiple Health Benefits and Methods Thereof
PL2793694T3 (pl) Układ do magnetokardiografii z przynależnym ergometrem